Analysis and perspectives - DelveInsight Business Research

Analysis And Perspectives

drugs-launched-in-second-half-2021
Assessment of Key Products that Got FDA Approva...

More than 20+ drugs by leading pharma players including Novartis, Sanofi, and others received FDA approval ...

progressive-parkinsons-disease-market
Evaluation of Rapidly Evolving Parkinson’s Dise...

Parkinson's disease treatment market to expand owing to novel therapies being developed by companies such a...

cybersecurity-in-healthcare-industry
Cybersecurity in Healthcare: Major Threats and ...

Cybersecurity in healthcare has deteriorated significantly over the last decade. Unfortunately, this trend ...

nerve-monitoring-market
The Evolving Neurofibromatosis Treatment Landscape

Pharmaceuticals like AstraZeneca, Array Biopharma, Novartis, are developing therapies to fulfill Neurofibro...

An Exploratory Analysis of the Rare and Inherited Pompe Disease
Pompe Disease: Causes, Symptoms, Diagnosis, Pat...

Pompe Disease Therapeutics market is evolving immensely with the active participation of key companies such...

biosimilar-market-trends
Analyzing the Key Trends Driving the Biosimilar...

Factors such as reduced healthcare costs, disease burden, patent expiry of biologics, and others are drivin...

pertussis-treatment-outlook
What is Driving the Pertussis Treatment Market ...

The DTP, DTaP, and TDaP are the key vaccines for Pertussis Treatment. Globally, pharma and biotech companie...

biosimilar-approvals-and-launches-2021
Insights into some of the Biosimilar Drugs that...

A slew of biosimilar drug approvals and product launches are scheduled for 2021. The first insulin biosimil...

Novel-Upcoming-Osteoporosis-Drugs-Market
What All You Need to Know About Evolving Osteop...

Novel therapies in the Osteoporosis domain by Teva Pharma, Haoma Medica, Enteris, others are expected to ch...

tigit-Inhibitor-landscape
T-cell Immunoglobulin and ITIM domain (TIGIT) I...

TIGIT Inhibitor has been identified as a promising emerging immune checkpoint target due to its widespread ...

Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.